Trial Information
A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors
Sponsor: Syneos Health™
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
